DrugPatentWatch Database Preview
Smithkline Beecham Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for SMITHKLINE BEECHAM, and when can generic versions of SMITHKLINE BEECHAM drugs launch?
SMITHKLINE BEECHAM has six approved drugs.
There are two US patents protecting SMITHKLINE BEECHAM drugs.
There are fifty-one patent family members on SMITHKLINE BEECHAM drugs in seventeen countries.
Summary for Smithkline Beecham
| International Patents: | 51 |
| US Patents: | 2 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 6 |
| Drug Master File Entries: | 2 |
| Patent Litigation for Smithkline Beecham: | See patent lawsuits for Smithkline Beecham |
Drugs and US Patents for Smithkline Beecham
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smithkline Beecham | RELAFEN | nabumetone | TABLET;ORAL | 019583-002 | Dec 24, 1991 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Smithkline Beecham | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-004 | Oct 20, 2006 | AB | RX | Yes | No | 7,268,156*PED | Start Trial | Y | Start Trial | ||
| Smithkline Beecham | COREG | carvedilol | TABLET;ORAL | 020297-004 | May 29, 1997 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Smithkline Beecham
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Smithkline Beecham | AXID | nizatidine | CAPSULE;ORAL | 019508-001 | Apr 12, 1988 | 4,760,075 | Start Trial |
| Smithkline Beecham | DYNACIRC | isradipine | CAPSULE;ORAL | 019546-001 | Dec 20, 1990 | 4,466,972 | Start Trial |
| Smithkline Beecham | COREG | carvedilol | TABLET;ORAL | 020297-001 | Sep 14, 1995 | RE40000*PED | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SMITHKLINE BEECHAM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 10 mg and 20 mg | ➤ Subscribe | 2008-03-18 |
| ➤ Subscribe | Extended-release Capsules | 80 mg | ➤ Subscribe | 2007-11-19 |
| ➤ Subscribe | Capsules | 1 g | ➤ Subscribe | 2008-11-10 |
| ➤ Subscribe | Extended-release Capsules | 40 mg | ➤ Subscribe | 2007-12-21 |
| ➤ Subscribe | Oral Solution | 15 mg/mL | ➤ Subscribe | 2008-05-14 |
International Patents for Smithkline Beecham Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2005533823 | Start Trial |
| South Korea | 101078636 | Start Trial |
| South Korea | 20110134952 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
